G-CSF Mobilized CD34+ Cells in Transplant

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-Cells

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
120 patients (estimated)
Sponsors
National Heart, Lung, and Blood Institute (NHLBI)
Tags
Allogeneic Stem Cell Transplant, CD34
Trial Type
Treatment
Last Update
3 months ago
SparkCures ID
1580
NCT Identifier
NCT01174108

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.